Sectral and Risperdal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sectral (acebutolol hydrochloride) and Risperdal (risperidone). Common drug interactions include cerebral haemorrhage among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Sectral and Risperdal. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.



On Jul, 18, 2026

58 people who take Sectral and Risperdal together, and have interactions are studied.

Sectral and Risperdal drug interactions.

What are the common drug interactions of Sectral and Risperdal, by gender? *:

female:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Confusional state
  4. Agitation (state of anxiety or nervous excitement)
  5. Insomnia (sleeplessness)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Fall
  8. Overdose
  9. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  10. Alpha 2 globulin increased

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Candida sepsis (candida in blood stream)
  4. Cerebral atrophy (decrement in size of brain)
  5. Cerebral haemorrhage (bleeding within the brain)
  6. Death
  7. Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  9. Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
  10. Facial palsy (paralysis of face nerve)

What are the common drug interactions of Sectral and Risperdal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Sudden death
  2. Death

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Fall
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Hypotension (abnormally low blood pressure)
  6. Insomnia (sleeplessness)
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Septic shock (shock due to blood infection)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Overdose

What are the existing conditions these people have? *

  1. Pain: 16 people, 27.59%
  2. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 13 people, 22.41%
  3. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 13 people, 22.41%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 13 people, 22.41%
  5. Agitation (state of anxiety or nervous excitement): 12 people, 20.69%
  6. Insomnia (sleeplessness): 6 people, 10.34%
  7. Cardiomyopathy (weakening of the heart muscle): 6 people, 10.34%
  8. Depression: 5 people, 8.62%

* Approximation only. Some reports may have incomplete information.

Do you take Sectral and Risperdal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sectral and Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Risperdal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sectral and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperdal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride and risperidone (the active ingredients of Sectral and Risperdal, respectively), and Sectral and Risperdal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: